Sai Parenterals Ltd
Q1 FY27, unaudited
- Revenue
- ₹52.78 Cr
- Profit after tax
- ₹8.88 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 52.78 | — | 162.25 |
| Other income | 3.41 | — | 2.74 |
| Total income | 56.19 | — | 164.99 |
| Employee benefit expense | 3.34 | — | 14.30 |
| Finance costs | 3.57 | — | 8.77 |
| Depreciation & amortisation | 1.36 | — | 5.78 |
| Total expenses | 44.36 | — | 146.22 |
| Profit before tax | 11.83 | — | 18.77 |
| Tax expense | 2.96 | — | 1.99 |
| Profit after tax | 8.88 | — | 16.78 |
| Total comprehensive income | 8.88 | — | 16.86 |
| Earnings per share, basic | ₹2.01 | ₹5.13 |
|---|---|---|
| Earnings per share, diluted | ₹2.01 | ₹5.13 |
Q1 FY27 — unaudited, from the company’s filing with NSE. Source
FY26 — from the company’s filing with NSE. Source
Why the dash
Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.
Earnings call
Q4 FY26Sai Parenterals reported its first earnings call as a listed company, discussing FY26 results and the acquisition of Australia-based Noumed Pharmaceuticals completed on 12th November 2025. Standalone FY26 revenue grew 30% to about INR162 crore while consolidated revenue rose to INR381 crore including partial-year Noumed contribution. Management outlined a INR440 crore capex program across India and Australia and set out targets for FY27 revenue and EBITDA margin.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 46 published by the exchange
25 Aug 2026
25 Aug 2026
Order win25 Aug 2026
20 Aug 2026
19 Aug 2026
19 Aug 2026
19 Aug 2026
18 Aug 2026
Transcript12 Aug 2026
12 Aug 2026
Presentation11 Aug 2026
11 Aug 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 25 Aug 2026.